Joseph C. Papa - May 19, 2022 Form 4 Insider Report for Prometheus Biosciences, Inc. (RXDX)

Role
Director
Signature
/s/ Timothy K. Andrews, attorney-in-fact for Joseph C. Papa
Stock symbol
RXDX
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
4
Date filed
5/20/2022, 07:26 PM
Previous filing
May 12, 2022
Next filing
Aug 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXDX Stock Option (Right to Buy) Award $0 +22.6K $0.00 22.6K May 19, 2022 Common Stock 22.6K $29.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in full upon the earlier to occur of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.